64 research outputs found
Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis
- …